Literature DB >> 3365653

Oligodendroglioma. A comparison of two grading systems.

J M Kros1, D Troost, C G van Eden, A J van der Werf, H B Uylings.   

Abstract

In order to compare the grading system for oligodendrogliomas described by M.T. Smith (1983) with the conventional grading system according to Kernohan (1938), specimens from 72 patients were graded according to both systems, and survival times of the patients were compared. Survival rates decline in older patients. No interaction between the age of the patient and the degree of the tumor was found. No influence of localization of the tumor on survival was found. Similar to the system of Kernohan, the grading system of Smith distinguishes between only three groups of patients with significantly different survival times. In Smith's Grade A and Kernohan's Grade 1 the longest survivals are found; while in Smith's Grade D and Kernohan's Grade 4 the shortest survivals are found. Smith's Grades B and C as well as Kernohan's Grades 2 and 3 were intermediate with respect to the survival times of the patients and did not significantly differ from each other. With the independently significant features (cell density, pleomorphism, and necrosis) evaluated according to simple on-off scoring, and with the reduction from four grades to three, the grading system according to Smith would provide a simple and good, concise grading system for oligodendrogliomas of the brain.

Entities:  

Mesh:

Year:  1988        PMID: 3365653     DOI: 10.1002/1097-0142(19880601)61:11<2251::aid-cncr2820611120>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.

Authors:  A Korshunov; A Golanov
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.

Authors:  Sarah F Smith; Judy M Simpson; Janice A Brewer; Lali H S Sekhon; Michael T Biggs; Raymond J Cook; Nicholas S Little
Journal:  J Neurooncol       Date:  2006-06-23       Impact factor: 4.130

Review 3.  Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults.

Authors:  Floris P Barthel; Kevin C Johnson; Pieter Wesseling; Roel G W Verhaak
Journal:  Neurol Clin       Date:  2018-08       Impact factor: 3.806

4.  Oligoastrocytomas: a clinicopathological study of 52 cases.

Authors:  H G Krouwer; S G van Duinen; W Kamphorst; P van der Valk; A Algra
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

5.  Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas.

Authors:  Abderrahmane Hamlat; Stephan Saikali; Jacques Chaperon; Beatrice Carsin-Nicol; Michéle Le Calve; Thierry Lesimple; Mohamed Ben-hassel; Yvon Guegan
Journal:  J Neurooncol       Date:  2006-09       Impact factor: 4.130

6.  Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria.

Authors:  C Daumas-Duport; M L Tucker; H Kolles; P Cervera; F Beuvon; P Varlet; N Udo; M Koziak; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

7.  The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas.

Authors:  M R Wacker; T Hoshino; D K Ahn; R L Davis; M D Prados
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 8.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

9.  The treatment of cerebral oligodendrogliomas with particular reference to features indicating malignancy: report of seventy-seven cases.

Authors:  M Turgut; K Tahta; O E Ozcan; B Onol
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

10.  Aggressive oligodendroglioma predicted by chromosome 10 restriction fragment length polymorphism analysis. Case study.

Authors:  J K Wu; R D Folkerth; Z Ye; B T Darras
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.